These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 35782909)

  • 1. Evaluation of lymphocyte count, T-cell subsets and neutrophil-to-lymphocyte ratio as early predictors for severity and outcome of COVID-19 disease-a report from a highly complex hospital in Brazil.
    Oliveira DC; Spiri BS; Schluga YC; Justus JLP; Lopes Neto FDN; Azambuja AP
    Hematol Transfus Cell Ther; 2023; 45(3):330-337. PubMed ID: 35782909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baseline T-lymphocyte subset absolute counts can predict both outcome and severity in SARS-CoV-2 infected patients: a single center study.
    Iannetta M; Buccisano F; Fraboni D; Malagnino V; Campogiani L; Teti E; Spalliera I; Rossi B; Di Lorenzo A; Palmieri R; Crea A; Zordan M; Vitale P; Voso MT; Andreoni M; Sarmati L
    Sci Rep; 2021 Jun; 11(1):12762. PubMed ID: 34140530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Coronavirus Disease 2019 (COVID-19) on Peripheral Blood Lymphocytes and Their Subsets in Children: Imbalanced CD4
    Mahmoudi S; Yaghmaei B; Sharifzadeh Ekbatani M; Pourakbari B; Navaeian A; Parvaneh N; Haghi Ashtiani MT; Mamishi S
    Front Pediatr; 2021; 9():643299. PubMed ID: 33937149
    [No Abstract]   [Full Text] [Related]  

  • 4. Poor Survival in COVID-19 Associated with Lymphopenia and Higher Neutrophile-Lymphocyte Ratio.
    Montiel-Cervantes LA; Medina G; Pilar Cruz-Domínguez M; Pérez-Tapia SM; Jiménez-Martínez MC; Arrieta-Oliva HI; Carballo-Uicab G; López-Pelcastre L; Camacho-Sandoval R
    Isr Med Assoc J; 2021 Mar; 23(3):153-159. PubMed ID: 33734627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of severe acute respiratory syndrome (SARS) coronavirus infection on peripheral blood lymphocytes and their subsets.
    He Z; Zhao C; Dong Q; Zhuang H; Song S; Peng G; Dwyer DE
    Int J Infect Dis; 2005 Nov; 9(6):323-30. PubMed ID: 16095942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of lymphocyte subsets and cytokine profiles of patients with COVID-19.
    Pan P; Du X; Zhou Q; Cui Y; Deng X; Liu C; Hu Z; Chen J; Yu X; Shi W
    Virol J; 2022 Mar; 19(1):57. PubMed ID: 35346253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The informative value of CD3+CD4+ and CD3+CD8+ T-cell count and cHIS scale as predictors of severe COVID-19 when using interleukin-6 receptor blockers in the in-hospital setting.
    Kruglova TS; Fomina DS
    Ter Arkh; 2022 Dec; 94(11):1294-1302. PubMed ID: 37167168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphopenia with Altered T Cell Subsets in Hospitalized COVID-19 Patients in Pune, India.
    Suryawanshi P; Takbhate B; Athavale P; Jali P; Memane N; Mirza S; Karandikar M; Kakrani AL; Kanitkar S; Gandham N; Barthwal MS; Dole S; Chaturvedi S; Pawale S; Tripathy A; Bhawalkar JS; Tripathy S
    Viral Immunol; 2023 Apr; 36(3):163-175. PubMed ID: 36897333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant Alteration of Circulating Lymphocyte Subsets in Small Cell Lung Cancer Patients Treated with Radiotherapy.
    Li H; Yu H; Lan S; Zhao D; Liu Y; Cheng Y
    Technol Cancer Res Treat; 2021; 20():15330338211039948. PubMed ID: 34851203
    [No Abstract]   [Full Text] [Related]  

  • 10. Characteristics and Predictive Value of T-lymphocyte Subset Absolute Counts in Patients with COVID-19-associated Acute Respiratory Failure: A Retrospective Study.
    Vadi S; Pednekar A; Suthar D; Sanwalka N; Ghodke K; Rabade N
    Indian J Crit Care Med; 2022 Nov; 26(11):1198-1203. PubMed ID: 36873590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral loads, lymphocyte subsets and cytokines in asymptomatic, mildly and critical symptomatic patients with SARS-CoV-2 infection: a retrospective study.
    Yin SW; Zhou Z; Wang JL; Deng YF; Jing H; Qiu Y
    Virol J; 2021 Jun; 18(1):126. PubMed ID: 34118952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fine Analysis of Lymphocyte Subpopulations in SARS-CoV-2 Infected Patients: Differential Profiling of Patients With Severe Outcome.
    Clavarino G; Leroy C; Epaulard O; Raskovalova T; Vilotitch A; Pernollet M; Dumestre-Pérard C; Defendi F; Le Maréchal M; Le Gouellec A; Audoin P; Bosson JL; Poignard P; Roustit M; Jacob MC; Cesbron JY
    Front Immunol; 2022; 13():889813. PubMed ID: 35911748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The predictive role of lymphocyte subsets and laboratory measurements in COVID-19 disease: a retrospective study.
    Wang L; Chen J; Zhao J; Li F; Lu S; Liu P; Liu XH; Huang Q; Wang H; Xu QN; Liu X; Yu S; Liu L; Lu H
    Ther Adv Respir Dis; 2021; 15():17534666211049739. PubMed ID: 34632871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic changes of T-lymphocyte subsets and the correlations with 89 patients with coronavirus disease 2019 (COVID-19).
    Huang M; Wang Y; Ye J; Da H; Fang S; Chen L
    Ann Transl Med; 2020 Sep; 8(18):1145. PubMed ID: 33240994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppressed T cell-mediated immunity in patients with COVID-19: A clinical retrospective study in Wuhan, China.
    Xu B; Fan CY; Wang AL; Zou YL; Yu YH; He C; Xia WG; Zhang JX; Miao Q
    J Infect; 2020 Jul; 81(1):e51-e60. PubMed ID: 32315725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptosis and immunophenotyping of peripheral blood lymphocytes in Iranian COVID-19 patients: Clinical and laboratory characteristics.
    Taghiloo S; Aliyali M; Abedi S; Mehravaran H; Sharifpour A; Zaboli E; Eslami-Jouybari M; Ghasemian R; Vahedi-Larijani L; Hossein-Nattaj H; Amjadi O; Rezazadeh H; Ajami A; Asgarian-Omran H
    J Med Virol; 2021 Mar; 93(3):1589-1598. PubMed ID: 32910458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic changes in lymphocyte subsets and parallel cytokine levels in patients with severe and critical COVID-19.
    Liu Y; Tan W; Chen H; Zhu Y; Wan L; Jiang K; Guo Y; Tang K; Xie C; Yi H; Kuang Y; Luo Y
    BMC Infect Dis; 2021 Jan; 21(1):79. PubMed ID: 33461503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early changes in immune cell subsets with corticosteroids in patients with solid tumors: implications for COVID-19 management.
    Marté JL; Toney NJ; Cordes L; Schlom J; Donahue RN; Gulley JL
    J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33219091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Lymphocyte Subsets, PD-1, and FAS (CD95) in COVID-19 Cancer Patients.
    Kandeel EZ; Refaat L; Bayoumi A; Nooh HA; Hammad R; Khafagy M; Abdellateif MS
    Viral Immunol; 2022 Sep; 35(7):491-502. PubMed ID: 35930238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphocyte Subset Alteration and Monocyte CD4 Expression Reduction in Patients with Severe COVID-19.
    Kazancioglu S; Yilmaz FM; Bastug A; Sakallı A; Ozbay BO; Buyuktarakci C; Bodur H; Yilmaz G
    Viral Immunol; 2021 Jun; 34(5):342-351. PubMed ID: 33264073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.